PATH $14.34 pre-market Jan 20 2026 (NYSE): AI demand keeps outlook mixed
Pre-market traders see PATH stock at $14.34, down -3.04% as volumes spike to 35,725,433.00 shares ahead of guidance season. UiPath Inc. (PATH) trades on the NYSE in the United States and the move reflects a mix of recent analyst updates, insider sales, and a market rotation into other AI plays. We assess valuation, recent earnings signals, and Meyka AI forecasts to frame a short-term trading setup and a 12-month outlook for investors.
PATH stock: Pre-market price action and liquidity
UiPath Inc. (PATH) opened pre-market at $14.91 and sits at $14.34 in early trading on the NYSE in the United States. Volume is 35,725,433.00, above the average volume of 24,124,703.00, signaling higher participation. The intraday range so far is $14.31 to $14.91, and the stock is closer to its one-year high of $19.84 than its low of $9.38.
PATH stock: Fundamentals and valuation metrics
UiPath reports EPS $0.42 and a trailing PE of 34.14, indicating premium multiple vs. some software peers. Price-to-sales is 4.94, price-to-book is 4.01, and free cash flow yield is 0.04 (4.06%). The company holds healthy liquidity with a current ratio of 2.54 and cash per share of $2.59.
PATH stock: Recent earnings, analyst view and news
UiPath last reported revenue of $411.11M and EPS of $0.16, beating consensus by $0.02 and showing 15.9% year-over-year revenue growth. Wall Street leans cautious: consensus target sits near $16.00 with most analysts at Hold. Insider selling has been notable, including CEO and CFO transactions disclosed in SEC filings. For market data and recent quotes see the Nasdaq earnings page and the CNBC PATH quote for trading context source source.
PATH stock: Technicals and trading setup for AI stocks
Short-term technicals show RSI 48.95, MACD histogram slightly negative, and ADX 18.02, indicating no strong trend. The 50-day average is $15.65 and the 200-day average is $13.32, placing PATH between key moving averages. Bollinger Bands middle is $16.63, giving a tight band for potential range trades.
PATH stock: Risks and opportunities for investors
Opportunities come from enterprise automation demand and embedded AI features in UiPath’s platform. The company spends 25.02% of revenue on R&D, supporting product innovation. Risks include receivables days at 116.59, ongoing insider sales, and a relatively high PE of 34.14 versus growth peers.
PATH stock: Meyka AI grade and forecast model
Meyka AI rates PATH with a score out of 100: 76.06 | Grade: B+ | Suggestion: BUY. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, analyst consensus, and forecasts. Meyka AI’s forecast model projects monthly $18.90 and yearly $16.65. Versus the current price $14.34, the one-year model implies an upside of 16.12%. Forecasts are model-based projections and not guarantees.
Final Thoughts
PATH stock trades at $14.34 pre-market on Jan 20 2026 with above-average volume and mixed signals from fundamentals and technicals. UiPath shows improving revenue growth and positive free cash flow, but valuation at a trailing PE of 34.14 and long receivables days raise near-term risk. Analysts sit mostly at Hold with a consensus target of $16.00, while Meyka AI’s model projects a one-year price of $16.65 and a monthly level of $18.90, implying a 16.12% and 31.80% upside respectively versus today’s price. Investors focused on AI stocks should weigh UiPath’s product-led growth and cash strength against execution and multiple compression risks. Meyka AI provides the grade and forecasts as data-driven inputs; they are not financial advice. Monitor the earnings announcement on 2026-03-11 and price reaction around the 50-day and 200-day moving averages for trading cues.
FAQs
What is the current price and pre-market move for PATH stock?
PATH stock is at $14.34 pre-market on Jan 20 2026, down -3.04% with volume 35,725,433.00, above the 50-day average of $15.65 and showing higher liquidity.
How does Meyka AI rate PATH stock and why does it matter?
Meyka AI rates PATH with a score of 76.06 (Grade B+, Suggestion: BUY). The grade factors in benchmark and sector comparisons, financial growth, metrics, analyst consensus, and model forecasts.
What are key valuation metrics for PATH stock I should watch?
Watch trailing PE 34.14, price-to-sales 4.94, free cash flow yield 4.06%, and cash per share $2.59. These metrics show premium valuation with improving cash generation.
When is the next earnings date for PATH stock and what matters?
UiPath’s next earnings announcement is scheduled for 2026-03-11. Focus on revenue growth, operating margin, and guidance for automation demand across banking and healthcare sectors.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
